These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 9690539)

  • 1. KAI1/CD82 expression in nonsmall cell lung carcinoma is a novel, favorable prognostic factor: an immunohistochemical analysis.
    Higashiyama M; Kodama K; Yokouchi H; Takami K; Adachi M; Taki T; Ishiguro S; Nakamori S; Yoshie O; Miyake M
    Cancer; 1998 Aug; 83(3):466-74. PubMed ID: 9690539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer.
    Adachi M; Taki T; Ieki Y; Huang CL; Higashiyama M; Miyake M
    Cancer Res; 1996 Apr; 56(8):1751-5. PubMed ID: 8620488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship between the levels of KAI1/CD82 and CD44 and the clinicopathological features of non-small cell lung cancer].
    Chen QY; Lin XM; Zhou JY; An Z; Yang L; Jiang ZY
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Feb; 27(2):101-4. PubMed ID: 14990184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of CD82/KAI1 and HIF-1α in non-small cell lung cancer and their relationship to vasculogenic mimicry].
    Wu S; Cheng Z; Yu L; Song W; Tao Y
    Zhongguo Fei Ai Za Zhi; 2011 Dec; 14(12):918-25. PubMed ID: 22152691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the correlation of vasculogenic mimicry, Notch4, DLL4, and KAI1/CD82 in the prediction of metastasis and prognosis in non-small cell lung cancer.
    Wang Y; Yang R; Wang X; Ci H; Zhou L; Zhu B; Wu S; Wang D
    Medicine (Baltimore); 2018 Dec; 97(52):e13817. PubMed ID: 30593175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel staging protocol for non-small-cell lung cancers according to MRP-1/CD9 and KAI1/CD82 gene expression.
    Adachi M; Taki T; Konishi T; Huang CI; Higashiyama M; Miyake M
    J Clin Oncol; 1998 Apr; 16(4):1397-406. PubMed ID: 9552043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma.
    Uchida S; Shimada Y; Watanabe G; Li ZG; Hong T; Miyake M; Imamura M
    Br J Cancer; 1999 Mar; 79(7-8):1168-73. PubMed ID: 10098753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and clinical significance of CD82/KAI1 and E-cadherin in non-small cell lung cancer.
    Shiwu WU; Lan Y; Wenqing S; Lei Z; Yisheng T
    Arch Iran Med; 2012 Nov; 15(11):707-12. PubMed ID: 23102249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation and expression of the metastasis suppressor gene KAI1 in esophageal squamous cell carcinoma.
    Miyazaki T; Kato H; Shitara Y; Yoshikawa M; Tajima K; Masuda N; Shouji H; Tsukada K; Nakajima T; Kuwano H
    Cancer; 2000 Sep; 89(5):955-62. PubMed ID: 10964324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients.
    Huang CI; Kohno N; Ogawa E; Adachi M; Taki T; Miyake M
    Am J Pathol; 1998 Sep; 153(3):973-83. PubMed ID: 9736046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of Gal-3 and CD82/KAI1 proteins in non-small cell lung cancer and their clinical significance].
    Wu SW; Yu L; Zhou L; Cheng ZN; Tao YS
    Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):124-8. PubMed ID: 23714667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KAI1/CD82 expression as a prognosic factor in sporadic colorectal cancer.
    Muneyuki T; Watanabe M; Yamanaka M; Shiraishi T; Isaji S
    Anticancer Res; 2001; 21(5):3581-7. PubMed ID: 11848527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmembrane 4 superfamily as a prognostic factor in pancreatic cancer.
    Sho M; Adachi M; Taki T; Hashida H; Konishi T; Huang CL; Ikeda N; Nakajima Y; Kanehiro H; Hisanaga M; Nakano H; Miyake M
    Int J Cancer; 1998 Oct; 79(5):509-16. PubMed ID: 9761121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of KAI1/CD82 expression in bone and soft tissue tumors is not associated with lung metastasis.
    Arihiro K; Inai K
    Pathol Res Pract; 2001; 197(9):627-33. PubMed ID: 11569927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [KAI1/CD82 and ME491/CD63 expression in non-small-cell carcinoma of the lung and prognosis].
    Adachi M; Taki T; Ieki Y; Ko S; Higashiyama S; Kodama K; Doi S; Miyake M
    Nihon Kyobu Geka Gakkai Zasshi; 1997 Mar; 45(3):398-401. PubMed ID: 9235357
    [No Abstract]   [Full Text] [Related]  

  • 16. Down-regulation of the metastasis suppressor protein KAI1/CD82 correlates with occurrence of metastasis, prognosis and presence of HPV DNA in human penile squamous cell carcinoma.
    Protzel C; Kakies C; Kleist B; Poetsch M; Giebel J
    Virchows Arch; 2008 Apr; 452(4):369-75. PubMed ID: 18305955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrin alpha3 expression as a prognostic factor in colon cancer: association with MRP-1/CD9 and KAI1/CD82.
    Hashida H; Takabayashi A; Tokuhara T; Taki T; Kondo K; Kohno N; Yamaoka Y; Miyake M
    Int J Cancer; 2002 Feb; 97(4):518-25. PubMed ID: 11802216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KAI1 metastasis suppressor protein is down-regulated during the progression of human endometrial cancer.
    Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ; Lu CH; Chiou LC
    Clin Cancer Res; 2003 Apr; 9(4):1393-8. PubMed ID: 12684410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transduction of KAI1/CD82 cDNA promotes hematogenous spread of human lung-cancer cells in natural killer cell-depleted SCID mice.
    Shinohara T; Nishimura N; Hanibuchi M; Nokihara H; Miki T; Hamada H; Sone S
    Int J Cancer; 2001 Oct; 94(1):16-23. PubMed ID: 11668473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological significance of cancer stem cells marked by CD133 and KAI1/CD82 expression in laryngeal squamous cell carcinoma.
    Yu L; Zhou L; Wu S; Gong X; Feng Z; Ma L; Zhu B; Yao N; Wang D; Dong H
    World J Surg Oncol; 2014 Apr; 12():118. PubMed ID: 24758564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.